Tris(trimethylsilyl) phosphite - CAS 1795-31-9
Catalog: |
BB013580 |
Product Name: |
Tris(trimethylsilyl) phosphite |
CAS: |
1795-31-9 |
Synonyms: |
tris(trimethylsilyl) phosphite |
IUPAC Name: | tris(trimethylsilyl) phosphite |
Description: | Tris(trimethylsilyl) phosphite (CAS# 1795-31-9) is used in the studies of bisphosphonic acids as effective inhibitor of glutamine synthetase, a promising approach for the discovery of novel drugs against tuberculosis. It also acts as a reagent in the preparation of substituted calix[4]arenes bearing one or two α-hydroxymethylphosphonic acid fragments at upper rim of macrocycle as inhibitors of glutathione S-transferase in vitro. |
Molecular Weight: | 298.54 |
Molecular Formula: | C9H27O3PSi3 |
Canonical SMILES: | C[Si](C)(C)OP(O[Si](C)(C)C)O[Si](C)(C)C |
InChI: | InChI=1S/C9H27O3PSi3/c1-14(2,3)10-13(11-15(4,5)6)12-16(7,8)9/h1-9H3 |
InChI Key: | VMZOBROUFBEGAR-UHFFFAOYSA-N |
Boiling Point: | 90 °C (20 torr) |
Purity: | > 97.0 % (T) |
Density: | 0.89 g/cm3 |
Appearance: | Colorless clear liquid |
MDL: | MFCD00015588 |
LogP: | 4.76780 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113429433-A | Additive for lithium ion battery electrolyte, lithium ion battery electrolyte and lithium ion battery | 20210618 |
CN-113328143-A | Non-aqueous electrolyte for lithium battery, preparation method of non-aqueous electrolyte and lithium ion battery | 20210528 |
CN-113270632-A | High-nickel ternary lithium ion battery electrolyte and lithium ion battery containing same | 20210513 |
CN-113078355-A | Ternary lithium ion battery electrolyte and ion battery thereof | 20210207 |
CN-112687846-A | Pre-metallization method of electrode | 20201229 |
PMID | Publication Date | Title | Journal |
20981332 | 20100615 | Superparamagnetic bifunctional bisphosphonates nanoparticles: a potential MRI contrast agent for osteoporosis therapy and diagnostic | Journal of osteoporosis |
21581900 | 20090110 | Hydro-nium (3-oxo-1-phosphono-1,3-dihydro-isobenzofuran-1-yl)phospho-nate | Acta crystallographica. Section E, Structure reports online |
853505 | 19770501 | Synthesis and anti-herpes simplex activity of analogues of phosphonoacetic acid | Journal of medicinal chemistry |
Complexity: | 180 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 298.10056132 |
Formal Charge: | 0 |
Heavy Atom Count: | 16 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 298.10056132 |
Rotatable Bond Count: | 6 |
Topological Polar Surface Area: | 27.7 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Phosphorus Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS